COLL
COLLEGIUM PHARMACEUTICAL, INCCompany with tickers: COLL
CIK
1267565
CUSIP
19459J104
Shares Outstanding
31,753,211
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-18 | Dieter David | EVP & General Counsel | Sell | 13,976 |
| 2026-03-17 | Dieter David | EVP & General Counsel | Tax | 8,840 |
| 2026-03-09 | Dieter David | EVP & General Counsel | Sell | 6,224 |
| 2026-03-03 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 46,417 |
| 2026-02-10 | Smith Thomas B | EVP and Chief Medical Officer | Award | 14,268 |
| 2026-02-10 | Tupper Colleen | EVP & Chief Financial Officer | Award | 26,421 |
| 2026-02-10 | Dieter David | EVP & General Counsel | Tax | 2,781 |
| 2026-02-10 | Dieter David | EVP & General Counsel | Award | 22,194 |
| 2026-02-10 | Karnani Vikram | Director, President and CEO | Tax | 11,296 |
| 2026-02-10 | Tupper Colleen | EVP & Chief Financial Officer | Tax | 11,861 |
| 2026-02-10 | Karnani Vikram | Director, President and CEO | Award | 79,264 |
| 2026-02-10 | Smith Thomas B | EVP and Chief Medical Officer | Tax | 5,897 |
| 2026-02-10 | Dreyer Scott | EVP & Chief Commercial Officer | Award | 19,023 |
| 2026-02-10 | Dreyer Scott | EVP & Chief Commercial Officer | Tax | 9,977 |
| 2025-12-08 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 11,125 |
| 2025-12-08 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 17,600 |
| 2025-12-08 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 17,600 |
| 2025-12-05 | Balice-Gordon Rita J. | Director | Sell | 3,650 |
| 2025-11-12 | Fallon John A. | Director | Convert | 15,000 |
| 2025-11-12 | Fallon John A. | Director | Sell | 34,853 |
| 2025-11-12 | Karnani Vikram | Director, President and CEO | Tax | 8,983 |
| 2025-11-12 | Fallon John A. | Director | Convert | 15,000 |
| 2025-11-06 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 25,142 |
| 2025-08-29 | Smith Thomas B | EVP and Chief Medical Officer | Sell | 17,478 |
| 2025-08-18 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 16,389 |
| 2025-08-18 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 16,389 |
| 2025-08-18 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 16,389 |
| 2025-08-15 | SANTINI GINO | Director | Convert | 15,000 |
| 2025-08-15 | SANTINI GINO | Director | Convert | 15,000 |
| 2025-08-15 | SANTINI GINO | Director | Sell | 5,405 |
| 2025-08-13 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 4,861 |
| 2025-08-13 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 4,861 |
| 2025-08-13 | Rubric Capital Management LP | 10% Owner | Sell | 25,000 |
| 2025-08-13 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 4,861 |
| 2025-08-08 | Freund John Gordon | Director | Other | 70,658 |
| 2025-08-08 | Freund John Gordon | Director | Sell | 11,659 |
| 2025-08-07 | Rubric Capital Management LP | 10% Owner | Other | 3,157,743 |
| 2025-06-09 | Freund John Gordon | Director | Other | 8,625 |
| 2025-06-09 | Freund John Gordon | Director | Convert | 15,000 |
| 2025-06-09 | Freund John Gordon | Director | Sell | 6,601 |
| 2025-06-09 | Freund John Gordon | Director | Convert | 15,000 |
| 2025-05-15 | Freund John Gordon | Director | Award | 9,791 |
| 2025-05-15 | Paya Carlos V | Director | Award | 19,582 |
| 2025-05-15 | Paya Carlos V | Director | Other | 0 |
| 2025-05-15 | Balice-Gordon Rita J. | Director | Award | 9,791 |
| 2025-05-15 | Fallon John A. | Director | Award | 9,791 |
| 2025-05-15 | BOHLIN GAREN G | Director | Award | 9,791 |
| 2025-05-15 | Lurker Nancy | Director | Award | 9,791 |
| 2025-05-15 | SANTINI GINO | Director | Award | 9,791 |
| 2025-05-15 | Freund John Gordon | Director | Other | 8,625 |
| 2025-03-21 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 18,881 |
| 2025-03-21 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 6,396 |
| 2025-03-20 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 1,927 |
| 2025-03-20 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 1,206 |
| 2025-03-17 | Dieter David | EVP & General Counsel | Award | 68,449 |
| 2025-03-17 | Dieter David | EVP & General Counsel | Other | 0 |
| 2025-03-14 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 2,255 |
| 2025-03-14 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 977 |
| 2025-03-11 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 10,445 |
| 2025-03-07 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 1,504 |
| 2025-03-07 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 2,348 |
| 2025-03-06 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 26,067 |
| 2025-03-06 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 3,295 |
| 2025-03-06 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 15,387 |
| 2025-03-06 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 1,949 |
| 2025-03-05 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 20,000 |
| 2025-03-04 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 40,000 |
| 2025-03-04 | Kuhlmann Shirley R. | EVP and General Counsel | Convert | 40,000 |
| 2025-03-04 | Kuhlmann Shirley R. | EVP and General Counsel | Convert | 40,000 |
| 2025-02-10 | Tupper Colleen | EVP & Chief Financial Officer | Award | 51,768 |
| 2025-02-10 | Tupper Colleen | EVP & Chief Financial Officer | Tax | 8,109 |
| 2025-02-10 | Kuhlmann Shirley R. | EVP and General Counsel | Award | 40,965 |
| 2025-02-10 | Kuhlmann Shirley R. | EVP and General Counsel | Tax | 9,826 |
| 2025-02-10 | Heffernan Michael Thomas | Director | Award | 4,820 |
| 2025-02-10 | Dreyer Scott | EVP & Chief Commercial Officer | Award | 45,016 |
| 2025-02-10 | Smith Thomas B | EVP and Chief Medical Officer | Award | 33,762 |
| 2025-02-10 | Smith Thomas B | EVP and Chief Medical Officer | Tax | 1,498 |
| 2025-02-10 | Dreyer Scott | EVP & Chief Commercial Officer | Tax | 7,953 |
| 2025-02-04 | Lurker Nancy | Director | Award | 12,726 |
| 2025-02-04 | Lurker Nancy | Director | Other | 0 |
| 2025-01-10 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 21,400 |
| 2025-01-10 | Kuhlmann Shirley R. | EVP and General Counsel | Convert | 27,500 |
| 2025-01-10 | Kuhlmann Shirley R. | EVP and General Counsel | Convert | 27,500 |
| 2024-11-12 | Karnani Vikram | Director, President and CEO | Other | 0 |
| 2024-11-12 | Karnani Vikram | Director, President and CEO | Award | 130,344 |
| 2024-11-12 | Karnani Vikram | Director, President and CEO | Award | 105,972 |
| 2024-09-13 | Smith Thomas B | EVP and Chief Medical Officer | Sell | 9,593 |
| 2024-09-06 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 977 |
| 2024-09-05 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 16,848 |
| 2024-06-03 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | 24,300 |
| 2024-05-28 | Tupper Colleen | EVP & Chief Financial Officer | Sell | 19,710 |
| 2024-05-24 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 23,791 |
| 2024-05-24 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 23,791 |
| 2024-05-24 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 56,807 |
| 2024-05-23 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | 51,209 |
| 2024-05-23 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 51,209 |
| 2024-05-23 | Dreyer Scott | EVP & Chief Commercial Officer | Convert | 51,209 |
| 2024-05-16 | Melincoff Gwen A | Director | Award | 7,693 |
| 2024-05-16 | Freund John Gordon | Director | Award | 7,693 |
| 2024-05-16 | McFarlane Neil F. | Director | Award | 7,693 |